Most lately, it has been discovered that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some big selection of endogenous opioids. Compared with most opioid receptors, this receptor acts as a scavenger https://tommyf601gev0.blogdemls.com/profile